TrialDiabetes, obesity & metabolism2018

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial.

Yu Hong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.